MS Guidelines

Question 1

What is the purpose of the NICE (2022) MS guideline?

Answer 1

To provide evidence-based recommendations for diagnosis and management of multiple sclerosis in adults.

Question 2

Who should diagnose MS according to NICE?

Answer 2

A consultant neurologist with expertise in MS.

Question 3

When should a person with suspected MS be referred?

Answer 3

Rapid referral to a neurologist when clinical features suggest MS.

Question 4

What diagnostic criteria are used for MS?

Answer 4

Clinical assessment supported by MRI demonstrating dissemination in time and space.

Question 5

Should disease-modifying therapy (DMT) be discussed early?

Answer 5

Yes, discuss DMT options as early as possible after diagnosis.

Question 6

Who should be involved in decisions about DMT?

Answer 6

The person with MS, considering benefits, risks, lifestyle, and preferences.

Question 7

How should relapses be managed?

Answer 7

Offer high-dose methylprednisolone to shorten relapse duration.

Question 8

Does steroid treatment alter the long-term course of MS?

Answer 8

No, it shortens relapse duration but does not change long-term progression.

Question 9

When should hospital admission be considered during relapse?

Answer 9

If symptoms are severe or complications arise.

Question 10

How should fatigue be managed?

Answer 10

Offer assessment, energy conservation strategies, exercise, and address contributing factors.

Question 11

What should be assessed when managing spasticity?

Answer 11

Impact on function, pain, sleep, and quality of life.

Question 12

What is first-line pharmacological treatment for spasticity?

Answer 12

Baclofen or gabapentin (depending on individual factors).

Question 13

When should specialist spasticity services be involved?

Answer 13

If spasticity is severe or not responding to first-line treatment.

Question 14

How should mobility problems be addressed?

Answer 14

Physiotherapy, exercise programmes, gait training, and mobility aids where needed.

Question 15

What is recommended for bladder dysfunction?

Answer 15

Assessment of bladder symptoms and referral to specialist continence services if needed.

Question 16

How should bowel dysfunction be managed?

Answer 16

Dietary advice, bowel programmes, and appropriate medication.

Question 17

How should pain be managed in MS?

Answer 17

Identify type of pain and manage according to neuropathic pain guidelines.

Question 18

How should cognitive problems be addressed?

Answer 18

Assessment and referral for neuropsychological support if needed.

Question 19

How should emotional and psychological symptoms be managed?

Answer 19

Screen for depression and anxiety and offer appropriate psychological or pharmacological treatment.

Question 20

What is recommended regarding multidisciplinary care?

Answer 20

Ongoing access to an MDT with expertise in MS.

Question 21

How often should MS be reviewed?

Answer 21

At least annually, or more frequently depending on clinical need.

Question 22

What should be discussed at regular reviews?

Answer 22

Disease progression, symptom control, medication side effects, mobility, mood, cognition, and social participation.

Question 23

What is the role of patient education in MS management?

Answer 23

Provide information about disease course, treatment options, lifestyle, and support services.

Question 24

Why is coordinated care important in MS?

Answer 24

To ensure comprehensive management of physical, psychological, and social needs.